Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin Schulman

Showing results (21-30 of 69) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|September 22, 2021
The No Surprises Act and Informed Financial ConsentBarak Richman, Mark Hall, Kevin Schulman
BMJ Global Health|October 15, 2021
Novel strategies to support global promotion of COVID-19 vaccinationStacy Wood, Muhammad Ali Pate, Kevin Schulman
Health Services Research|October 18, 2025
Who Contracts on Diagnosis Related Groups and How Are They Priced? Evidence From Hospital Price TransparencyHarrison Koos, David Scheinker, Kevin Schulman, et al.
NEJM Catalyst Innovations in Care Delivery|July 8, 2026
Artificial Intelligence in the Clinic: Don't Pay for the Tool, Pay for the CareSharif Vakili, Ashwin Nayak, Andrew Conrad, et al.
Health Affairs Scholar|May 17, 2024
Pre-pandemic assessment: a decade of progress in electronic health record adoption among U.S. hospitalsJohn Xuefeng Jiang, Kangkang Qi, Ge Bai, et al.
JCO Oncology Practice|January 10, 2025
The Price Is NOT Right: Payers' Roles in Addressing Financial ToxicityManali I Patel, Angela Riley, Lee Newcomer, et al.
Health Services Research|September 19, 2002
The determinants of HMOs' contracting with hospitals for bypass surgeryDarrell J Gaskin, José J Escarce, Kevin Schulman, et al.
Medical Teacher|November 25, 2010
Addressing the systems-based practice requirement with health policy content and educational technologyAlisa Nagler, Kathryn Andolsek, Kristin Dossary, et al.
Plos One|February 14, 2019
Evaluating the quality of antihypertensive drugs in Lagos State, NigeriaElizabeth Thithi Ndichu, Kelechi Ohiri, Oluwafemi Sekoni, et al.
The Milbank Quarterly|September 18, 2024
A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key StakeholdersIselin Dahlen Syversen, Kevin Schulman, Aaron S Kesselheim, et al.
Pageof 7

Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|September 22, 2021
The No Surprises Act and Informed Financial ConsentBarak Richman, Mark Hall, Kevin Schulman
BMJ Global Health|October 15, 2021
Novel strategies to support global promotion of COVID-19 vaccinationStacy Wood, Muhammad Ali Pate, Kevin Schulman
Health Services Research|October 18, 2025
Who Contracts on Diagnosis Related Groups and How Are They Priced? Evidence From Hospital Price TransparencyHarrison Koos, David Scheinker, Kevin Schulman, et al.
NEJM Catalyst Innovations in Care Delivery|July 8, 2026
Artificial Intelligence in the Clinic: Don't Pay for the Tool, Pay for the CareSharif Vakili, Ashwin Nayak, Andrew Conrad, et al.
Health Affairs Scholar|May 17, 2024
Pre-pandemic assessment: a decade of progress in electronic health record adoption among U.S. hospitalsJohn Xuefeng Jiang, Kangkang Qi, Ge Bai, et al.
JCO Oncology Practice|January 10, 2025
The Price Is NOT Right: Payers' Roles in Addressing Financial ToxicityManali I Patel, Angela Riley, Lee Newcomer, et al.
Health Services Research|September 19, 2002
The determinants of HMOs' contracting with hospitals for bypass surgeryDarrell J Gaskin, José J Escarce, Kevin Schulman, et al.
Medical Teacher|November 25, 2010
Addressing the systems-based practice requirement with health policy content and educational technologyAlisa Nagler, Kathryn Andolsek, Kristin Dossary, et al.
Plos One|February 14, 2019
Evaluating the quality of antihypertensive drugs in Lagos State, NigeriaElizabeth Thithi Ndichu, Kelechi Ohiri, Oluwafemi Sekoni, et al.
The Milbank Quarterly|September 18, 2024
A Comparative Analysis of International Drug Price Negotiation Frameworks: An Interview Study of Key StakeholdersIselin Dahlen Syversen, Kevin Schulman, Aaron S Kesselheim, et al.
Pageof 7